Refreshing results…
SARS-CoV-2 variants of concern have acquired mutations associated with an increased spike cleavage
UploadSARS-CoV-2 spike E484K mutation reduces antibody neutralisation
Download from doi.orgDrug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
UploadTOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation
UploadReplication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes
Download from doi.orgPlitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
UploadSARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
Download from doi.orgDiscovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Download from www.nature.comMissing publications? Search for publications with a matching author name.